{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:31:06Z","timestamp":1718152266484},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,11]]},"DOI":"10.7759\/cureus.62176","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T18:08:38Z","timestamp":1718129318000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Cisplatin-Induced Encephalopathy: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Fadoua","family":"Jebrouni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan","family":"Bailal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouhsine","family":"Omari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaouthar","family":"Khater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmae","family":"Bali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ouissam","family":"Al Jarroudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami Aziz","family":"Brahmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Afqir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Cisplatin-based chemotherapy of human cancers","volume":"11","author":"Brown A","year":"2019","unstructured":"Brown A, Kumar S, Tchounwou PB. Cisplatin-based chemotherapy of human cancers. J Cancer Sci Ther. 2019, 11:97.","journal-title":"J Cancer Sci Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.9b00204","article-title":"Advances in toxicological research of the anticancer drug cisplatin","volume":"32","author":"Qi L","year":"2019","unstructured":"Qi L, Luo Q, Zhang Y, Jia F, Zhao Y, Wang F. Advances in toxicological research of the anticancer drug cisplatin. Chem Res Toxicol. 2019, 32:1469-86. 10.1021\/acs.chemrestox.9b00204","journal-title":"Chem Res Toxicol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1594020","article-title":"Primary concurrent chemoradiation in head and neck cancers with weekly cisplatin chemotherapy: analysis of compliance, toxicity and survival","volume":"21","author":"Iqbal MS","year":"2017","unstructured":"Iqbal MS, Chaw C, Kovarik J, et al.. Primary concurrent chemoradiation in head and neck cancers with weekly cisplatin chemotherapy: analysis of compliance, toxicity and survival. Int Arch Otorhinolaryngol. 2017, 21:171-7. 10.1055\/s-0036-1594020","journal-title":"Int Arch Otorhinolaryngol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-008-0876-6","article-title":"Central and peripheral nervous system toxicity of common chemotherapeutic agents","volume":"63","author":"Sioka C","year":"2009","unstructured":"Sioka C, Kyritsis AP. Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol. 2009, 63:761-7. 10.1007\/s00280-008-0876-6","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199801000-00013","article-title":"Cisplatin-induced non-convulsive encephalopathy","volume":"9","author":"Lyass O","year":"1998","unstructured":"Lyass O, Lossos A, Hubert A, Gips M, Peretz T. Cisplatin-induced non-convulsive encephalopathy. Anticancer Drugs. 1998, 9:100-4. 10.1097\/00001813-199801000-00013","journal-title":"Anticancer Drugs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2016.11.011","article-title":"50th anniversary of cisplatin [Article in French]","volume":"104","author":"Rancoule C","year":"2017","unstructured":"Rancoule C, Guy JB, Vallard A, Ben Mrad M, Rehailia A, Magn\u00e9 N. 50th anniversary of cisplatin [Article in French]. Bull Cancer. 2017, 104:167-76. 10.1016\/j.bulcan.2016.11.011","journal-title":"Bull Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2279","article-title":"Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: a retrospective evaluation","volume":"29","author":"Astolfi L","year":"2013","unstructured":"Astolfi L, Ghiselli S, Guaran V, et al.. Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: a retrospective evaluation. Oncol Rep. 2013, 29:1285-92. 10.3892\/or.2013.2279","journal-title":"Oncol Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.194863","article-title":"Seizure following chemotherapy (paclitaxel and cisplatin) in a patient of carcinoma cervix","volume":"48","author":"Dana R","year":"2016","unstructured":"Dana R, Spartacus RK, Mutha S, Bhat P. Seizure following chemotherapy (paclitaxel and cisplatin) in a patient of carcinoma cervix. Indian J Pharmacol. 2016, 48:736-8. 10.4103\/0253-7613.194863","journal-title":"Indian J Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200307000-00009","article-title":"Cisplatin-induced encephalopathy and seizures","volume":"14","author":"Steeghs N","year":"2003","unstructured":"Steeghs N, de Jongh FE, Sillevis Smitt PA, van den Bent MJ. Cisplatin-induced encephalopathy and seizures. Anticancer Drugs. 2003, 14:443-6. 10.1097\/00001813-200307000-00009","journal-title":"Anticancer Drugs"},{"key":"ref10","article-title":"Epileptic seizures associated with cisplatin administration","volume":"66","author":"Mead GM","year":"1982","unstructured":"Mead GM, Arnold AM, Green JA, Macbeth FR, Williams CJ, Whitehouse JM. Epileptic seizures associated with cisplatin administration. Cancer Treat Rep. 1982, 66:1719-22.","journal-title":"Cancer Treat Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1989.tb136535.x","article-title":"Focal encephalopathy after cisplatin therapy","volume":"150","author":"Gorman DJ","year":"1989","unstructured":"Gorman DJ, Kefford R, Stuart-Harris R. Focal encephalopathy after cisplatin therapy. Med J Aust. 1989, 150:399-401. 10.5694\/j.1326-5377.1989.tb136535.x","journal-title":"Med J Aust"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.4103\/2279-042X.192464","article-title":"Gemcitabine and cisplatin induced posterior reversible encephalopathy syndrome: a case report with review of literature","volume":"5","author":"Kabre RS","year":"2016","unstructured":"Kabre RS, Kamble KM. Gemcitabine and cisplatin induced posterior reversible encephalopathy syndrome: a case report with review of literature. J Res Pharm Pract. 2016, 5:297-300.","journal-title":"J Res Pharm Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800215)45:4<764::aid-cncr2820450425>3.0.co;2-g","article-title":"Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year-old man","volume":"15","author":"Berman IJ","unstructured":"Berman IJ, Mann MP. Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year-old man. Cancer. 15:764-6. 10.1002\/1097-0142(19800215)45:4&lt;764::aid-cncr2820450425&gt;3.0.co;2-g","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00963","article-title":"Chemotherapy-related encephalopathy with super-refractory status epilepticus in a child with osteosarcoma: a case report with a review of literature","volume":"10","author":"Di Genova L","year":"2019","unstructured":"Di Genova L, Perruccio K, Celani MG, Mastrodicasa E, Cantisani TA, Esposito S, Caniglia M. Chemotherapy-related encephalopathy with super-refractory status epilepticus in a child with osteosarcoma: a case report with a review of literature. Front Pharmacol. 2019, 10:963. 10.3389\/fphar.2019.00963","journal-title":"Front Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(88)90052-2","article-title":"Cisplatin-induced hypomagnesemia with seizures: a case report and review of the literature","volume":"1","author":"Bellin SL","year":"1988","unstructured":"Bellin SL, Selim M. Cisplatin-induced hypomagnesemia with seizures: a case report and review of the literature. Gynecol Oncol. 1988, 1:104-13. 10.1016\/0090-8258(88)90052-2","journal-title":"Gynecol Oncol"},{"key":"ref16","article-title":"Cortical blindness and seizures possibly related to cisplatin, vinblastine, and bleomycin treatment of ovarian dysgerminoma","volume":"93","author":"Young DC","year":"1993","unstructured":"Young DC, Mitchell A, Kessler J, Christman JE. Cortical blindness and seizures possibly related to cisplatin, vinblastine, and bleomycin treatment of ovarian dysgerminoma. J Am Osteopath Assoc. 1993, 93:502-4, 507.","journal-title":"J Am Osteopath Assoc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.6.392","article-title":"Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin","volume":"1","author":"Cohen RJ","year":"1983","unstructured":"Cohen RJ, Cuneo RA, Cruciger MP, Jackman AE. Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin. J Clin Oncol. 1983, 1:392-3. 10.1200\/JCO.1983.1.6.392","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/02841860310010754","article-title":"Acute reversible encephalopathy after repeated low-dose cisplatin infusions and concomitant radiotherapy for cancer of the tongue","volume":"42","author":"Vihinen PP","year":"2003","unstructured":"Vihinen PP, K\u00e4tk\u00e4 KM, Johansson RK, Vihinen TA, Salminen EK. Acute reversible encephalopathy after repeated low-dose cisplatin infusions and concomitant radiotherapy for cancer of the tongue. Acta Oncol. 2003, 42:237-9. 10.1080\/02841860310010754","journal-title":"Acta Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-007-1732-z","article-title":"Severe reversible toxic encephalopathy induced by cisplatin in a patient with cervical carcinoma receiving combined radiochemotherapy","volume":"183","author":"Sterzing F","year":"2007","unstructured":"Sterzing F, Grehn C, Dinkel J, Krempien R, Hartung G, Debus J, Harms W. Severe reversible toxic encephalopathy induced by cisplatin in a patient with cervical carcinoma receiving combined radiochemotherapy. Strahlenther Onkol. 2007, 183:487-9. 10.1007\/s00066-007-1732-z","journal-title":"Strahlenther Onkol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005850","article-title":"A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin","volume":"96","author":"Cherniawsky H","year":"2017","unstructured":"Cherniawsky H, Merchant N, Sawyer M, Ho M. A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin. Medicine (Baltimore). 2017, 96:e5850. 10.1097\/MD.0000000000005850","journal-title":"Medicine (Baltimore)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-6-409","article-title":"Cisplatin-induced posterior reversible encephalopathy syndrome and successful re-treatment in a patient with non-seminomatous germ cell tumor: a case report","volume":"6","author":"Zahir MN","year":"2012","unstructured":"Zahir MN, Masood N, Shabbir-Moosajee M. Cisplatin-induced posterior reversible encephalopathy syndrome and successful re-treatment in a patient with non-seminomatous germ cell tumor: a case report. J Med Case Rep. 2012, 6:409. 10.1186\/1752-1947-6-409","journal-title":"J Med Case Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/0169-5002(95)00503-x","article-title":"Subacute encephalopathic toxicity of cisplatin","volume":"13","author":"Verschraegen C","year":"1995","unstructured":"Verschraegen C, Conrad CA, Hong WK. Subacute encephalopathic toxicity of cisplatin. Lung Cancer. 1995, 13:305-9. 10.1016\/0169-5002(95)00503-x","journal-title":"Lung Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2019.07.157","article-title":"Combination of chemotherapy and radiotherapy: a thirty years evolution","volume":"23","author":"Hennequin C","year":"2019","unstructured":"Hennequin C, Guillerm S, Quero L. Combination of chemotherapy and radiotherapy: a thirty years evolution. Cancer Radiother. 2019, 23:662-5. 10.1016\/j.canrad.2019.07.157","journal-title":"Cancer Radiother"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010502","article-title":"Radiotherapy alone and with concurrent chemotherapy for nasopharyngeal carcinoma. A retrospective study","volume":"97","author":"Katano A","year":"2018","unstructured":"Katano A, Takahashi W, Yamashita H, et al.. Radiotherapy alone and with concurrent chemotherapy for nasopharyngeal carcinoma. A retrospective study. Medicine (Baltimore). 2018, 97:e0502. 10.1097\/MD.0000000000010502","journal-title":"Medicine (Baltimore)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt163","article-title":"Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma","volume":"24","author":"Wu X","year":"2013","unstructured":"Wu X, Huang PY, Peng PJ, et al.. Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma. Ann Oncol. 2013, 24:2131-6. 10.1093\/annonc\/mdt163","journal-title":"Ann Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/1758-3284-3-30","article-title":"Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma","volume":"3","author":"Dechaphunkul T","year":"2011","unstructured":"Dechaphunkul T, Pruegsanusak K, Sangthawan D, Sunpaweravong P. Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma. Head Neck Oncol. 2011, 3:30. 10.1186\/1758-3284-3-30","journal-title":"Head Neck Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(97)00116-8","article-title":"Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer\u2014results from a phase I trial","volume":"38","author":"Hoffmann W","year":"1997","unstructured":"Hoffmann W, Belka C, Schmidberger H, Budach W, Bochtler H, Hess CF, Bamberg M. Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer\u2014results from a phase I trial. Int J Radiat Oncol Biol Phys. 1997, 38:691-6. 10.1016\/s0360-3016(97)00116-8","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.3.792","article-title":"Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study","volume":"19","author":"Eisbruch A","year":"2001","unstructured":"Eisbruch A, Shewach DS, Bradford CR, et al.. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study. J Clin Oncol. 2001, 19:792-9. 10.1200\/JCO.2001.19.3.792","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyw100","article-title":"Chemoradiotherapy with weekly low-dose docetaxel and cisplatin concurrent with radiation for patients with locally advanced nasopharyngeal carcinoma, followed by adjuvant chemotherapy for selected patients","volume":"46","author":"Nakahara S","year":"2016","unstructured":"Nakahara S, Hanamoto A, Seo Y, et al.. Chemoradiotherapy with weekly low-dose docetaxel and cisplatin concurrent with radiation for patients with locally advanced nasopharyngeal carcinoma, followed by adjuvant chemotherapy for selected patients. Jpn J Clin Oncol. 2016, 46:903-10. 10.1093\/jjco\/hyw100","journal-title":"Jpn J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/259969-management-of-cisplatin-induced-encephalopathy-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T18:08:47Z","timestamp":1718129327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/259969-management-of-cisplatin-induced-encephalopathy-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.62176","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,11]]}}}